Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (7 quarters reported)
$167M in Q1 2016 → $43.1M now. Hover for any quarter.
As reported for the quarter ended September 30, 2017. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Editas Medicine, Inc. | 100.0% | Trimmed 36% | 1,797,144 | $43.1M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 6 quarters.
quarter ended September 30, 2017 · filed November 14, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Editas Medicine, Inc. | Trimmed | −1,000,002 | −$24M | 100.0% |
quarter ended June 30, 2017 · filed August 14, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Editas Medicine, Inc. | Trimmed | −1,000,000 | −$16.8M | 100.0% |
quarter ended March 31, 2017 · filed May 15, 2017
No position changes this quarter.
quarter ended December 31, 2016 · filed February 14, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Editas Medicine, Inc. | Trimmed | −359,027 | −$5.83M | 100.0% |
| Rapid7, Inc. | Exited | −48,460 | −$855K | — |
quarter ended September 30, 2016 · filed November 09, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Editas Medicine, Inc. | Trimmed | −500,000 | −$6.74M | 98.5% |
quarter ended June 30, 2016 · filed August 15, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Rapid7, Inc. | Trimmed | −403,407 | −$5.08M | 0.5% |
Loading...
